Expert Tip from Apexus

img
img

TIP: Master manufacturer refund challenges with actionable steps.


Managing manufacturer refunds in the 340B Drug Pricing Program

Read More »
Industry Insights Logo

Pillr Health: A New Era of Innovation in 340B and Beyond

SPONSORED CONTENT

The healthcare landscape is evolving rapidly, and with it, the need for stronger, smarter partnerships has never been greater. Covered entities are navigating a time of uncertainty, where operational challenges, regulatory scrutiny, and resource constraints are putting unprecedented pressure on healthcare organizations. That’s why

Read More »

5 Questions to Assess the Effectiveness of Your 340B Pharmacy Program and Position it to Optimize Outcomes

Industry Insights Logo

Compliance with Inflation Reduction ACT (IRA) and Associated Maximum Fair Price (MFP) Rules for 340B Covered Entities

SPONSORED CONTENT

The evolving landscape of pharmaceutical pricing and reimbursement models presents complex challenges for manufacturers and pharmacies. One of the most significant developments is the introduction of the Inflation Reduction Act (IRA) and its Maximum Fair Price (MFP) provisions, aimed at reducing drug

Read More »

Expert Tip from Maxor

img
img

TIP: Use AI to optimize your health system’s 340B program.


Artificial intelligence (AI) is transforming healthcare, offering

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live